News
2d
Zacks Investment Research on MSNKRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock UpShares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a phase I/II study evaluating its eye drop KB801 for the treatment of ...
Monsoon season causes a spike in eye infections due to humidity and pollution. Preventive hygiene and timely treatment are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results